Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi Arabia

BACKGROUND: Two vaccines for COVID-19 have been approved and administered in the Kingdom of Saudi Arabia (KSA); Pfizer-BioNtech BNT162b2 and AstraZeneca-Oxford AZD1222 vaccines. The purpose of this study was to describe the real-world data on the outcome of single dose of these COVID-19 vaccines in...

Descripción completa

Detalles Bibliográficos
Autores principales: Alharbi, Naif Khalaf, Al-Tawfiq, Jaffar A., Alghnam, Suliman, Alwehaibe, Amal, Alasmari, Abrar, Alsagaby, Suliman A., Alsubaie, Faisal, Alshomrani, Majid, Farahat, Fayssal M., Bosaeed, Mohammad, Alharbi, Ahmad, Aldibasi, Omar, Assiri, Abdullah M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986276/
https://www.ncbi.nlm.nih.gov/pubmed/35472755
http://dx.doi.org/10.1016/j.jiph.2022.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986276/
https://www.ncbi.nlm.nih.gov/pubmed/35472755
http://dx.doi.org/10.1016/j.jiph.2022.04.001

Ejemplares similares